KIAA1191 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.864600E-01
Normal-vs-Stage2
5.883400E-01
Normal-vs-Stage3
3.207400E-01
Normal-vs-Stage4
1.981440E-01
Stage1-vs-Stage2
6.204800E-01
Stage1-vs-Stage3
8.318200E-02
Stage1-vs-Stage4
8.392300E-02
Stage2-vs-Stage3
6.679600E-02
Stage2-vs-Stage4
2.429200E-01
Stage3-vs-Stage4
3.206400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.171200E-01
Normal-vs-AfricanAmerican
8.274200E-01
Normal-vs-Asian
6.921000E-01
Caucasian-vs-AfricanAmerican
7.587200E-01
Caucasian-vs-Asian
8.625800E-01
AfricanAmerican-vs-Asian
7.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.696600E-01
Normal-vs-Female
6.678800E-01
Male-vs-Female
4.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.999800E-01
Normal-vs-Age(41-60Yrs)
1.712640E-01
Normal-vs-Age(61-80Yrs)
8.509600E-01
Normal-vs-Age(81-100Yrs)
8.432200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.668370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.502600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.268600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.201450E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.944500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.204000E-01
Normal-vs-Daily Drinker
8.377400E-01
Normal-vs-Weekly Drinker
8.129400E-01
Normal-vs-Occasional Drinker
3.543000E-01
Normal-vs-Social Drinker
2.224600E-01
Non Drinker-vs-Daily Drinker
8.059600E-01
Non Drinker-vs-Weekly Drinker
7.742400E-01
Non Drinker-vs-Occasional Drinker
1.277640E-01
Non Drinker-vs-Social Drinker
1.309620E-01
Daily Drinker-vs-Weekly Drinker
9.474000E-01
Daily Drinker-vs-Occasional Drinker
2.398000E-01
Daily Drinker-vs-Social Drinker
1.953960E-01
Weekly Drinker-vs-Occasional Drinker
3.157000E-01
Weekly Drinker-vs-Social Drinker
3.068000E-01
Occasional Drinker-vs-Social Drinker
9.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.254410E-01
Normal-vs-Grade 2
7.021000E-03
Normal-vs-Grade 3
8.760100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.857800E-01
Grade 1-vs-Grade 3
2.265000E-01
Grade 1-vs-Grade 4
1.254410E-01
Grade 2-vs-Grade 3
7.201400E-01
Grade 2-vs-Grade 4
7.021000E-03
Grade 3-vs-Grade 4
8.760100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.513800E-01
Normal-vs-NonDiabetic
5.506000E-01
Diabetic-vs-NonDiabetic
2.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.230000E-01
Normal-vs-NoPancreatitis
6.455000E-01
Pancreatitis-vs-NoPancreatitis
2.940400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.704400E-01
Normal-vs-N1
6.330000E-01
N0-vs-N1
7.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.929000E-01
Normal-vs-TP53-NonMutant
7.083400E-01
TP53-Mutant-vs-TP53-NonMutant
4.030000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
